Search Results - "Sologub, O S"

Hyperhomocysteinemia in Parkinson’s disease – new variant of complications of ongoing therapy or specific biochemical marker of the disease? by I. V. Litvinenko, M. M. Odinak, O. S. Sologub, V. I. Mogilnaya, V. M. Schmeleva, A. A. Saharovskaya

“…Homocysteine is an amino acid with excitotoxic effect on the nervous system, and its elevated level is an independent risk factor for cerebrovascular disease…”
Get full text

Direct switch from conventional levodopa to stalevo (levodopa/carbidopa/entacapone) improves quality of life in Parkinson's disease: results of an open-label clinical study by Litvinenko, I V, Odinak, M M, Mogil'naia, V I, Sologub, O S, Sakharovskaia, A A

“…The most effective symptomatic treatment for Parkinson's disease (PD) is levodopa/dopa decarboxylase (DDC)-inhibitor or conventional levodopa. However, after a…”
Get more information